PubMed

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial.

Hibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlethwaite JR, Neylan JF, Snydman DR, Freeman R, Lorber MI, Rubin RH.

Ann Intern Med. 1995 Jul 1;123(1):18-26.PMID: 7762909 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.

Turgeon N, Fishman JA, Basgoz N, Tolkoff-Rubin NE, Doran M, Cosimi AB, Rubin RH.

Transplantation. 1998 Dec 27;66(12):1780-6.PMID: 9884276 [PubMed - indexed for MEDLINE]Related articles

[Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease]

Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.

Rev Invest Clin. 2002 May-Jun;54(3):198-203. Spanish. PMID: 12183888 [PubMed - indexed for MEDLINE]Related articles

Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy.

Brennan DC, Garlock KA, Lippmann BA, Buller RS, Gaudreault-Keener M, Lowell JA, Miller SB, Shenoy S, Howard TK, Storch GA.

J Am Soc Nephrol. 1997 Jan;8(1):118-25.PMID: 9013456 [PubMed - indexed for MEDLINE]Related articlesFree article

Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients.

Conti DJ, Freed BM, Singh TP, Gallichio M, Gruber SA, Lempert N.

Arch Surg. 1995 Nov;130(11):1217-21; discussion 1221-2.PMID: 7487465 [PubMed - indexed for MEDLINE]Related articles

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial.

Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T.

Ann Intern Med. 1994 Mar 1;120(5):375-81.PMID: 8304654 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir.

Turgeon N, Fishman JA, Doran M, Basgoz N, Tolkoff-Rubin NE, Cosimi AB, Rubin RH.

Transpl Infect Dis. 2000 Mar;2(1):2-10.PMID: 11429003 [PubMed - indexed for MEDLINE]Related articles

Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.

Ahsan N, Holman MJ, Yang HC.

Clin Transplant. 1997 Dec;11(6):633-9.PMID: 9408699 [PubMed - indexed for MEDLINE]Related articles

Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.

Gotti E, Suter F, Baruzzo S, Perani V, Moioli F, Remuzzi G.

Clin Transplant. 1996 Dec;10(6 Pt 1):550-5.PMID: 8996777 [PubMed - indexed for MEDLINE]Related articles

Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy.

Morales E, Andrés A, González E, Herrero JC, Muñoz MA, Ortiz M, Espejo B, Lumbreras C, Morales JM, Aguado JM.

Transplant Proc. 2002 Feb;34(1):73-4. No abstract available. PMID: 11959191 [PubMed - indexed for MEDLINE]Related articles

Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease.

Taber DJ, Ashcraft E, Baillie GM, Berkman S, Rogers J, Baliga PK, Rajagopalan PR, Lin A, Emovon O, Afzal F, Chavin KD.

Transpl Infect Dis. 2004 Sep;6(3):101-9.PMID: 15569225 [PubMed - indexed for MEDLINE]Related articles

Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.

Said T, Nampoory MR, Johny KV, Pacsa AS, Mini Abraham P, Nair MP, Abdel-Haleem M, Samhan M, Al-Mousawi M.

Transplant Proc. 2004 Jul-Aug;36(6):1847-9.PMID: 15350495 [PubMed - indexed for MEDLINE]Related articles

Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.

Strippoli GF, Hodson EM, Jones C, Craig JC.

Transplantation. 2006 Jan 27;81(2):139-45. Review.PMID: 16436954 [PubMed - indexed for MEDLINE]Related articles

Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity.

Künzle N, Petignat C, Francioli P, Vogel G, Seydoux C, Corpataux JM, Sahli R, Meylan PR.

Transpl Infect Dis. 2000 Sep;2(3):118-26.PMID: 11429022 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis.

Gabardi S, Magee CC, Baroletti SA, Powelson JA, Cina JL, Chandraker AK.

Pharmacotherapy. 2004 Oct;24(10):1323-30.PMID: 15628830 [PubMed - indexed for MEDLINE]Related articles

Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin.

Gutiérrez CA, Chaparro C, Krajden M, Winton T, Kesten S.

Chest. 1998 Apr;113(4):924-32.PMID: 9554627 [PubMed - indexed for MEDLINE]Related articlesFree article

Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.

Becker BN, Becker YT, Leverson GE, Simmons WD, Sollinger HW, Pirsch JD.

Am J Kidney Dis. 2002 May;39(5):1088-95.PMID: 11979354 [PubMed - indexed for MEDLINE]Related articles

A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.

Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM, et al.

N Engl J Med. 1992 Apr 30;326(18):1182-6.PMID: 1313549 [PubMed - indexed for MEDLINE]Related articles

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial.

Winston DJ, Ho WG, Bartoni K, Du Mond C, Ebeling DF, Buhles WC, Champlin RE.

Ann Intern Med. 1993 Feb 1;118(3):179-84.PMID: 8380243 [PubMed - indexed for MEDLINE]Related articlesFree article

Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial.

Reed EC, Wolford JL, Kopecky KJ, Lilleby KE, Dandliker PS, Todaro JL, McDonald GB, Meyers JD.

Ann Intern Med. 1990 Apr 1;112(7):505-10.PMID: 2156476 [PubMed - indexed for MEDLINE]Related articles